Nicolaus Kröger

Nicolaus Kröger is a researcher affiliated with the University of Hamburg's Medical Faculty, specifically within the Department of Hematology and Oncology. His work focuses on translational and clinical research in hematologic malignancies, with a strong emphasis on hematopoietic stem cell transplantation (HSCT), CAR T-cell therapy, and targeted treatments for diseases like myelofibrosis, myelodysplastic syndromes, and acute leukemias. He collaborates extensively with international groups such as the European Society for Blood and Marrow Transplantation (EBMT) and contributes to guideline development for post-transplant complications.

Research interests include improving transplant outcomes through molecular profiling, optimizing timing and conditioning regimens, and addressing immune-related challenges such as graft-versus-host disease. His studies frequently address high-risk patient populations, including elderly patients and those with refractory malignancies. He also investigates novel therapies like bispecific antibodies and JAK inhibitors in post-transplant management.

Key contributions include developing predictive models for survival after HSCT using machine learning, analyzing long-term outcomes of CAR T-cell therapies, and evaluating the impact of genetic mutations on transplant success. His work bridges basic science and clinical practice, aiming to personalize treatment strategies in hematology.